ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 709,75
0,00%
Dow Jones
43 487,83
0,78%
DAX
20 903,39
1,31%
Brent Oil
79,755
-0,57%
Bitcoin
0,00000000
0,00%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Lifecore Biomedical Inc (LFCR) Cours

Lifecore Biomedical Inc

Lifecore Biomedical Inc (LFCR)

NASDAQ
6,48
0,04
(0,62%)
Fermé 20 Janvier 10:00PM
Retardé de 15 minutes
6,47
-0,01
(-0,15%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
6,48
Prix Achat
6,18
Prix Vente
9,01
Volume échangé
82 529
6,38 Fourchette du Jour 6,55
3,6793 Plage de 52 semaines 8,90
Cap du marché
239,924M
Clôture Veille
6,44
Ouverture
6,51
Dernière Transaction
10
@
6.4
Dernière heure de transaction
Volume financier
US$ 533 083
VWAP
6,4593
Volume moyen (3 m)
259 257
Actions en circulation
37 025 331
Rendement du Dividende
-
Ratio Cours sur Bénéfices
19,94
Bénéfice par action (BPA)
0,32
Chiffre d'affairess
128,26M
Bénéfice net
12,01M

À propos de Lifecore Biomedical Inc

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hy... Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Show more

Secteur
Plastics,resins,elastomers
Industrie
Plastics,resins,elastomers
Site Web
www.lifecore.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Lifecore Biomedical Inc est coté dans le secteur Plastics,resins,elastomers de la NASDAQ avec le ticker LFCR. Le dernier cours de clôture d'Lifecore Biomedical était de US$6,44. Au cours de la dernière année, les actions de Lifecore Biomedical ont été négociées dans une fourchette de prix de US$ 3,6793 à US$ 8,90.

Lifecore Biomedical compte actuellement 37 025 331 actions en circulation. La capitalisation boursière d'Lifecore Biomedical est de US$238,44 million. Lifecore Biomedical a un ratio cours/bénéfice (ratio PE) de 19.94.

LFCR Dernières nouvelles

Plus de nouvelles

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

17 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

17 Janvier 2025
Edgar (US Regulatory)

Lifecore Biomedical Announces Special Stockholder Meeting

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

17 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE...

07 Janvier 2025
GlobeNewswire Inc.

Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

06 Janvier 2025
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

02 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

02 Janvier 2025
Edgar (US Regulatory)

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately...

02 Janvier 2025
GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

26 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.48866.585.952247336.37142195CS
4-0.57-8.085106382987.057.785.654110286.82897401CS
121.0318.89908256885.457.995.3952592576.89181271CS
260.9918.03278688525.497.993.67932360715.87401075CS
52-0.22-3.283582089556.78.93.67932223995.87306339CS
156-2.6-28.63436123359.0811.4551.523259005.89788462CS
260-2.6-28.63436123359.0811.4551.523259005.89788462CS

LFCR - Frequently Asked Questions (FAQ)

What is the current Lifecore Biomedical share price?
The current share price of Lifecore Biomedical is US$ 6,48
How many Lifecore Biomedical shares are in issue?
Lifecore Biomedical has 37 025 331 shares in issue
What is the market cap of Lifecore Biomedical?
The market capitalisation of Lifecore Biomedical is USD 238,44M
What is the 1 year trading range for Lifecore Biomedical share price?
Lifecore Biomedical has traded in the range of US$ 3,6793 to US$ 8,90 during the past year
What is the PE ratio of Lifecore Biomedical?
The price to earnings ratio of Lifecore Biomedical is 19,94
What is the cash to sales ratio of Lifecore Biomedical?
The cash to sales ratio of Lifecore Biomedical is 1,87
What is the reporting currency for Lifecore Biomedical?
Lifecore Biomedical reports financial results in USD
What is the latest annual turnover for Lifecore Biomedical?
The latest annual turnover of Lifecore Biomedical is USD 128,26M
What is the latest annual profit for Lifecore Biomedical?
The latest annual profit of Lifecore Biomedical is USD 12,01M
What is the registered address of Lifecore Biomedical?
The registered address for Lifecore Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Lifecore Biomedical website address?
The website address for Lifecore Biomedical is www.lifecore.com
Which industry sector does Lifecore Biomedical operate in?
Lifecore Biomedical operates in the PLASTICS,RESINS,ELASTOMERS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LFCR
Lifecore Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés